Blog - Page 3268 of 5440

MondayApr 04, 2011 7:12 am

Acadia Pharmaceuticals Inc. (ACAD) Announces Extended Drug Discovery Partnership with Allergan Inc. (AGN)

Acadia Pharmaceuticals Inc., a biopharmaceutical company that focuses on drug discovery and clinical development of novel treatments for the central nervous system, recently announced that it has extended its drug development and discovery partnership with Allergan, Inc. The alliance is mainly focused on the discovery of new techniques for glaucoma and other ophthalmic indications and was originally established in March of 2003. Both parties have now extended the research term of this partnership for an extra year, now through March 2012. ACADIA also has two other collaborative projects with Allergan, which have led to clinical programs for chronic pain and…

MondayApr 04, 2011 7:07 am

China TMK Battery Systems (DFEL) Reports Q4, FY2010 Results

China TMK Battery Systems Inc., a Chinese manufacturer and distributor of customized rechargeable battery solutions to global consumer product companies, recently posted its financial results for the fourth quarter and full year ended December 31, 2010. The company reported a 38.8 percent increase in fourth quarter 2010 revenues to $19.9 million, driven by expanded sales efforts and increased demand for TMK's products from both existing and new customers. Total cost of sales increased 43.9 percent to $15.3 million for the fourth quarter of 2010 compared to the same period in 2009. Gross profit increased 24.7 percent to $4.7 million, with…

MondayApr 04, 2011 7:05 am

Roomlinx Inc. (RMLX) Posts YoY Improvements for Q4, FY2010

Roomlinx Inc., a developer of hotel interactive TV applications, Friday announced improved fourth-quarter and full-year 2010 financial performance, reflecting ongoing increased revenues and gross profits. The company reported fourth-quarter revenues at $1.83 million, up 136 percent for the fourth quarter of 2009. Revenues for full-year ended December 31, 2010, were $4.49 million, an 84 percent increase over full year 2009 revenues. The company attributes 74 percent of the annual increase to increased installations, hardware sales and recurring revenue streams of its media and entertainment products; 26 percent is attributable to the revenue streams acquired from Canadian Communications, LLC. Roomlinx' gross…

FridayApr 01, 2011 10:45 am

Tivus, Inc. (TIVU) Begins to Realize Potential with First Installations in Luxury Hotel for Largest REIT in U.S.

Most strong aggressive growth business models have a component of negotiating agreements with large, industry leaders to capitalize on the strength of those larger companies and achieve quick industry recognition. This is the goal of most small-capitalization companies, whether it is a biotech firm looking to work with Pfizer or a mining company hoping to strike a deal with Barrick Gold Corp. Moving forward from the development stage to becoming a profitable organization is much easier when one of the majors sees value in your product and incorporates it into part of their business plan. Tivus, Inc., an Omaha, Nebraska-based…

FridayApr 01, 2011 10:24 am

Deltek, Inc. (PROJ) Gains Even Greater Foothold in Government Contractor Sector, Acquires Washington Management Group and FedSources

Deltek, www.deltek.com – the enterprise software developer and information solutions provider to a host of government contractors/agencies and professional services firms around the world, reported today an all-cash transaction of $26M, whereby the Company has acquired Washington Management Group (WMG), in addition to its FedSources (FSI) and FedSources Consulting (FSI Consulting) businesses. President and CEO of PROJ, was extremely pleased with the move, saying that it represents a huge new opportunity to expand the solutions platform as a whole and to more fully engage the some 4k government contractors currently served by PROJ. The Company has built a name for…

FridayApr 01, 2011 10:21 am

Transgenomic, Inc. (TBIO) to Present at 2011 American Association for Cancer Research Meeting

In a short period of time Transgenomic, Inc. has evolved into a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis. Today, the company took a major step towards prominence with the announcement they will be making a presentation at the American Association for Cancer Research (AACR) meeting in Orlando, Florida on April 2-6 of this year. The presentation will be based upon completed studies by the company’s scientists. The studies employ the company’s high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker. Katherine Richardson, Ph.D, who serves as the Vice President of Research…

FridayApr 01, 2011 10:20 am

China Biologic Products, Inc. (CBPO) Reports Record Annual Sales and Net Income

China Biologic Products, the largest non-state-owned plasma based biopharmaceutical company in China, has reported record sales and net income for the year ended December 31, 2010. Sales for the Shandong Province based company increased 17.4% to $139.7 million for the year, compared to $119.0 million in 2009. Non-GAAP adjusted net income was $39.0 million for 2010, compared with $31.5 million for 2009. The company indicated that the revenue increase was due primarily to a general increase in the price and volume of plasma based products. Sales from human albumin product increased approximately 13.4% to $67.1 million, accounting for approximately 48.0%…

FridayApr 01, 2011 9:30 am

Coates International Ltd. (COTE) Signs Letter of Intent to Merge with Chinese Firm

Coates International Ltd. has spent over 15 years developing a patented spherical rotary valve CSRV internal combustion engine. This engine runs on a number of different fuels including gasoline, natural gas, ethanol, methanol, diesel and hydrogen. The engine has reduced maintenance requirements, reduced fuel consumption, reduced emissions and increased power. The company announced today that it has signed a letter of intent to merge with an industrial engine and generator manufacturing company in China. The merger is subject to certain conditions and governmental approvals, including raising capital internationally. The Chinese manufacturer currently employs more than 2,000 skilled plant workers and…

FridayApr 01, 2011 8:51 am

VIASPACE, Inc. (VSPC) Posts Q4, FY2010 Results reflecting Substantial Increase in Revenues

VIASPACE Inc., a clean energy company focused on providing products and technology for renewable and alternative energy, today reported its financial results for the fourth-quarter and year ended December 31, 2010. Fourth quarter 2010 total revenues were reported at $1,040,000, up more than 22% from the $851,000 that was reported for the same period in 2009. Cost of revenues totaled $752,000 in Q4 2010, compared to $541,000 in Q4 2009. Gross profit for the quarter was $288,000, compared to gross profit of $310,000 a year earlier. Total operating expenses for the quarter were $922,000, including $860,000 of selling, general and…

FridayApr 01, 2011 8:33 am

Apthera Announces Merger Agreement with RXi Pharmaceuticals (RXII)

Yesterday, Apthera Inc. announced that it has entered into a merger agreement with RXi Pharmaceuticals Corp., who will acquire Apthera. The merger will help initiate the Phase III trial for the new breast cancer drug NeuVax. NeuVax is a peptide-based immunotherapy for low-to-intermediate HER2+ breast cancer patients who can't take Herceptin. It is expected to enter Phase III clinical trials in 2012, under an FDA approved Special Protocol Assessment. Apthera, Inc. is a biotech company that is developing and commercializing a series of immunotherapies for the treatment of HER2-positive cancers. Apthera's products are currently in clinical trials, which are attempting…

Site Search

Company Search